Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SSGJ-609A by Sunshine Guojian Pharmaceutical Shanghai for Solid Tumor: Likelihood of Approval
SSGJ-609A is under clinical development by Sunshine Guojian Pharmaceutical Shanghai and currently in Phase I for Solid Tumor. According to...